# Oliceridine for Gastrointestinal Dysfunction

> **NCT07650812** · NA · NOT_YET_RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 176 (estimated)

## Conditions studied

- Gastrointestinal Dysfunction

## Interventions

- **DRUG:** Experimental: Oliceridine group
- **DRUG:** Active Comparator: Classical opioid group

## Key facts

- **NCT ID:** NCT07650812
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-12-15
- **Final completion:** 2027-12-30
- **Target enrollment:** 176 (ESTIMATED)
- **Last updated:** 2026-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07650812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07650812, "Oliceridine for Gastrointestinal Dysfunction". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07650812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*